Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryosuke Ono

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 31, 2022
Pre-treatment of oncolytic reovirus improves tumor accumulation and intratumoral distribution of PEG-liposomesMaho Eguchi, Seiya Hirata, Ikuho Ishigami, et al.
Intestinal Research|April 25, 2025
Efficacy and safety of etrasimod in Japanese patients with ulcerative colitis: results from a phase 2 dose-ranging studyKen Takeuchi, Hiroshi Nakase, Tadakazu Hisamatsu, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
A Comparison of the Pharmacokinetics and Drug Safety Among East Asian PopulationsMasayo Oishi, Shintaro Hiro, Nobushige Matsuoka, et al.
NPJ Dementia|May 9, 2025
Post-symptomatic NLRP3 inhibition rescues cognitive impairment and mitigates amyloid and tau driven neurodegenerationAnick Auger, Rania Faidi, Alexis D Rickman, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 31, 2022
Pre-treatment of oncolytic reovirus improves tumor accumulation and intratumoral distribution of PEG-liposomesMaho Eguchi, Seiya Hirata, Ikuho Ishigami, et al.
Intestinal Research|April 25, 2025
Efficacy and safety of etrasimod in Japanese patients with ulcerative colitis: results from a phase 2 dose-ranging studyKen Takeuchi, Hiroshi Nakase, Tadakazu Hisamatsu, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
A Comparison of the Pharmacokinetics and Drug Safety Among East Asian PopulationsMasayo Oishi, Shintaro Hiro, Nobushige Matsuoka, et al.
NPJ Dementia|May 9, 2025
Post-symptomatic NLRP3 inhibition rescues cognitive impairment and mitigates amyloid and tau driven neurodegenerationAnick Auger, Rania Faidi, Alexis D Rickman, et al.
Pageof 3